The Female Hormone Test is designed to be completed with one blood test early in your menstrual cycle.

This timing gives the clearest baseline snapshot of key reproductive, thyroid, adrenal and androgen-related hormones before ovulation starts to shift hormone levels later in the cycle.

Take your blood test between day 2 and day 5 of your cycle.

Day 1 is the first day of proper bleeding, not spotting.

For example:

This early-cycle window is the best time to assess baseline hormone signalling.

Female hormones change across the menstrual cycle.

Testing early in the cycle helps capture your hormones before the larger changes that happen around ovulation and the luteal phase.

This allows clearer assessment of:

This gives a useful view of how your hormonal system is functioning at the start of the cycle.

Because this test is only taken once early in the cycle, it does not measure peak progesterone after ovulation.

Progesterone usually rises after ovulation and is best assessed later in the cycle.

This means the test can show your early-cycle progesterone baseline, but it cannot confirm whether you ovulated or whether your luteal-phase progesterone production was strong in that cycle.

If your cycles are irregular but you still bleed, take the test between day 2 and day 5 of your next period.

If your cycle length varies, that is okay. The key is to test early in the bleed, rather than trying to predict ovulation.

If your periods are very infrequent, absent, or you are unsure when your next bleed will happen, you can still complete the test. Your results will be interpreted with that context in mind.

If possible, wait until your next cycle and complete the test between day 2 and day 5.

If you have already completed the test outside this window, the results may still be useful, but interpretation may be more limited because hormones shift throughout the cycle.

The further away the test is from the early-cycle window, the more cautiously results need to be interpreted.

Yes, but interpretation depends on the type of contraception and your reason for testing.

The combined pill suppresses ovulation and changes your natural hormone signalling.

This means your results will reflect the effect of the pill, not your unmedicated cycle.

The test may still help explore symptoms such as fatigue, mood changes, low libido or acne while using the pill, but it cannot accurately assess your natural ovulation pattern or fertility hormones while you are taking it.

These methods can affect ovulation, hormone signalling and bleeding patterns.

Your results may reflect a modified hormonal state rather than your natural cycle.

Interpretation focuses on your symptoms and current hormonal environment, not a full assessment of natural cycle health.

The copper IUD is non-hormonal and does not suppress ovulation.

If you have regular cycles, testing between day 2 and day 5 should reflect your natural early-cycle hormone baseline.

If your goal is to understand your natural cycle, ovulation or fertility hormones, testing is best done after stopping hormonal contraception and once natural cycles have resumed.

A short adjustment period is often needed before results stabilise.

Hormonal contraception does not usually “fix” hormone imbalance. It overrides the natural cycle. Testing while on hormonal contraception can show the effect of that override, but it cannot fully reveal your underlying cycle physiology.

Yes.

Perimenopause can involve changes in cycle regularity, ovulation, oestrogen patterns and progesterone production.

An early-cycle hormone test can help assess baseline hormone signalling and identify patterns that may be contributing to symptoms such as:

Because perimenopause can be hormonally variable, results are interpreted alongside symptoms and cycle history rather than as a standalone diagnosis.

Testing hormones at a random point in the cycle can be misleading.

Oestrogen, LH, FSH and progesterone can change significantly depending on where you are in your cycle.

Testing between day 2 and day 5 gives a more consistent baseline and reduces the risk of misinterpreting normal cycle changes as abnormal results.

The Female Hormone Test is taken once, between day 2 and day 5 of your cycle.

It provides a useful early-cycle snapshot of your baseline hormone function.

It does not measure peak progesterone after ovulation, so it cannot fully assess ovulation or luteal-phase progesterone production.

Your results are interpreted in the context of your symptoms, cycle pattern, contraception use and health goals.